Welcome to the 15th IHEM 2022
H. Gisslinger
AOP Health welcome
G. Fischer
CHAIRS: A. Mullally & M. Doubek
Role of inflammation in MPN
A. Fleischman
Clonal evolution of MPN
R. Skoda
COFFEE BREAK
CHAIRS: T. Barbui & J. Schwarz
Unmet need in ET
A. Alvarez - Larrán
How I treat ET
R. Kušec
Patient case IFN in ET
M. Krauth
EARLY INTERVENTION IN PV - AIMING FOR DISEASE MODIFICATION
CHAIRS: J.J Kiladjian & H. Gisslinger
Pre-clinical aspects
A. Mullally
IFN guidelines
T. Barbui
Practical considerations
M. Griesshammer
LUNCH BREAK
CHAIRS: V. Buxhofer-Ausch & A. Hatalová
Ropeg for low risk PV - Academic question or reality?
P. Schafhausen
Pre-treated PV
S. Papageorgiou
CHIP patient
M. Egyed
Switch patient case
T. Sliwa
Combination therapy
H. Gisslinger
Efficacy of interferon in PV - A matter of dose?
J. Göthert
COFFEE BREAK
CHAIR: A. Burchert & J. Góra-Tybor
TKIs - A backbone with limitations
F. Stegelmann
IFN in CML - a critical review
A. Burchert
CHAIRS: D. Wolf & M. Egyed
Pre- PMF - Where are we heading to?
H. Gisslinger
Pre- PMF patient cases
V. Buxhofer-Ausch
MF - How I treat
F. Passamonti
Secondary AML
D. Wolf
New compounds
J.J Kiladjian
